Spotlight Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3953 Point Eden Way, Hayward, California...Phone Number
(510) 284-4799Website
www.spotlighttx.comRevenue
<$5 MillionIndustry
About Spotlight Therapeutics
Established in mid-2018, Spotlight Therapeutics is a privately held biotechnology company advancing a pipeline of cell-targeted in vivo CRISPR gene editing therapies. Spotlight's proprietary technology platform TAGE (Targeted Active Gene Editors) is a new class of biologics, CRISPR effectors engineered for direct delivery in vivo, to achieve cell-selective therapeutic genome editing. Spotlight's pipeline is advancing its modular programmable CRISPR effectors towards clinical studies in immuno-oncology, ophthalmic diseases and hemoglobinopathies. The company is headquartered in Hayward, California.Explore more
Spotlight Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Spotlight Therapeutics
Compare insights from companies similar to Spotlight Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Spotlight Therapeutics
<$5M
11-50
Private
$66.5M
2018
AQ
Alison QuanExecutive Administrator & Manager, Office
Spotlight Therapeutics Tech Stack
A closer look at the technologies used by Spotlight Therapeutics
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Spotlight Therapeutics
Sign Up For FreeTo access detailed company insights
Established in mid-2018, Spotlight Therapeutics is a privately held biotechnology company advancing a pipeline of cell-targeted in vivo CRISPR gene editing therapies. Spotlight's proprietary technology platform TAGE (Targeted Active Gene Editors) is a new class of biologics, CRISPR effectors engineered for direct delivery in vivo, to achieve cell-s... Read More
